vs

Side-by-side financial comparison of DuPont (DD) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

DuPont is the larger business by last-quarter revenue ($1.7B vs $1.4B, roughly 1.2× PACS Group, Inc.). DuPont runs the higher net margin — 9.8% vs 4.4%, a 5.4% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 4.0%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs -27.2%).

DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder.

DD vs PACS — Head-to-Head

Bigger by revenue
DD
DD
1.2× larger
DD
$1.7B
$1.4B
PACS
Growing faster (revenue YoY)
PACS
PACS
+14.4% gap
PACS
18.4%
4.0%
DD
Higher net margin
DD
DD
5.4% more per $
DD
9.8%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
-27.2%
DD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DD
DD
PACS
PACS
Revenue
$1.7B
$1.4B
Net Profit
$164.0M
$59.7M
Gross Margin
35.8%
Operating Margin
7.0%
Net Margin
9.8%
4.4%
Revenue YoY
4.0%
18.4%
Net Profit YoY
3022.5%
EPS (diluted)
$0.36
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DD
DD
PACS
PACS
Q1 26
$1.7B
Q4 25
$-2.5B
$1.4B
Q3 25
$3.1B
$1.3B
Q2 25
$3.3B
$1.3B
Q1 25
$3.1B
$1.3B
Q4 24
$3.1B
$1.1B
Q3 24
$3.2B
$1.0B
Q2 24
$3.2B
$981.4M
Net Profit
DD
DD
PACS
PACS
Q1 26
$164.0M
Q4 25
$-126.0M
$59.7M
Q3 25
$-123.0M
$52.4M
Q2 25
$59.0M
$51.0M
Q1 25
$-589.0M
$28.5M
Q4 24
$-118.0M
$1.9M
Q3 24
$454.0M
$15.6M
Q2 24
$178.0M
$-10.9M
Gross Margin
DD
DD
PACS
PACS
Q1 26
35.8%
Q4 25
Q3 25
38.9%
Q2 25
37.3%
Q1 25
37.4%
Q4 24
36.4%
Q3 24
37.4%
17.1%
Q2 24
37.1%
22.3%
Operating Margin
DD
DD
PACS
PACS
Q1 26
Q4 25
7.0%
Q3 25
10.6%
6.4%
Q2 25
9.4%
6.2%
Q1 25
-14.0%
3.8%
Q4 24
1.4%
1.7%
Q3 24
18.4%
2.2%
Q2 24
9.3%
0.1%
Net Margin
DD
DD
PACS
PACS
Q1 26
9.8%
Q4 25
4.9%
4.4%
Q3 25
-4.0%
3.9%
Q2 25
1.8%
3.9%
Q1 25
-19.2%
2.2%
Q4 24
-3.8%
0.2%
Q3 24
14.2%
1.5%
Q2 24
5.6%
-1.1%
EPS (diluted)
DD
DD
PACS
PACS
Q1 26
$0.36
Q4 25
$-0.30
$0.42
Q3 25
$-0.29
$0.32
Q2 25
$0.14
$0.31
Q1 25
$-1.41
$0.17
Q4 24
$-0.28
$-0.03
Q3 24
$1.08
$0.10
Q2 24
$0.42
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DD
DD
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$710.0M
$197.0M
Total DebtLower is stronger
$3.2B
$353.2M
Stockholders' EquityBook value
$14.2B
$946.8M
Total Assets
$21.4B
$5.6B
Debt / EquityLower = less leverage
0.22×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DD
DD
PACS
PACS
Q1 26
$710.0M
Q4 25
$715.0M
$197.0M
Q3 25
$2.0B
$355.7M
Q2 25
$1.8B
$294.2M
Q1 25
$1.8B
$287.5M
Q4 24
$1.9B
$157.7M
Q3 24
$1.6B
$49.5M
Q2 24
$1.5B
$73.4M
Total Debt
DD
DD
PACS
PACS
Q1 26
$3.2B
Q4 25
$3.1B
$353.2M
Q3 25
$7.0B
Q2 25
$5.3B
Q1 25
$5.3B
Q4 24
$5.3B
$411.9M
Q3 24
$7.2B
Q2 24
$7.2B
Stockholders' Equity
DD
DD
PACS
PACS
Q1 26
$14.2B
Q4 25
$13.9B
$946.8M
Q3 25
$22.9B
$871.3M
Q2 25
$23.1B
$806.8M
Q1 25
$22.8B
$750.2M
Q4 24
$23.4B
$709.6M
Q3 24
$24.2B
$660.0M
Q2 24
$23.3B
$572.1M
Total Assets
DD
DD
PACS
PACS
Q1 26
$21.4B
Q4 25
$21.6B
$5.6B
Q3 25
$38.0B
$5.6B
Q2 25
$36.6B
$5.5B
Q1 25
$36.0B
$5.5B
Q4 24
$36.6B
$5.2B
Q3 24
$37.5B
$4.5B
Q2 24
$36.6B
$3.9B
Debt / Equity
DD
DD
PACS
PACS
Q1 26
0.22×
Q4 25
0.23×
0.37×
Q3 25
0.31×
Q2 25
0.23×
Q1 25
0.23×
Q4 24
0.23×
0.58×
Q3 24
0.30×
Q2 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DD
DD
PACS
PACS
Operating Cash FlowLast quarter
$-3.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
6.1%
Cash ConversionOCF / Net Profit
-0.06×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DD
DD
PACS
PACS
Q1 26
Q4 25
$-700.0M
$-3.4M
Q3 25
$497.0M
$204.8M
Q2 25
$381.0M
$52.6M
Q1 25
$382.0M
$150.2M
Q4 24
$564.0M
$64.6M
Q3 24
$737.0M
$209.2M
Q2 24
$527.0M
$34.8M
Free Cash Flow
DD
DD
PACS
PACS
Q1 26
Q4 25
$-850.0M
Q3 25
$379.0M
Q2 25
$265.0M
Q1 25
$133.0M
Q4 24
$403.0M
Q3 24
$628.0M
Q2 24
$425.0M
FCF Margin
DD
DD
PACS
PACS
Q1 26
Q4 25
33.4%
Q3 25
12.3%
Q2 25
8.1%
Q1 25
4.3%
Q4 24
13.0%
Q3 24
19.7%
Q2 24
13.4%
Capex Intensity
DD
DD
PACS
PACS
Q1 26
6.1%
Q4 25
-5.9%
Q3 25
3.8%
Q2 25
3.6%
Q1 25
8.1%
Q4 24
5.2%
Q3 24
3.4%
Q2 24
3.2%
Cash Conversion
DD
DD
PACS
PACS
Q1 26
Q4 25
-0.06×
Q3 25
3.91×
Q2 25
6.46×
1.03×
Q1 25
5.28×
Q4 24
33.78×
Q3 24
1.62×
13.39×
Q2 24
2.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons